Your Life Science Network Cambridge HEALTHTECH...Gene Therapy Bioproduction Aug. 16-17 • Boston,...

RESEARCH • COLLABORAT ION • ADVANCEMENT

Cambridge Innovation InstituteCHI is a division of

Conference, Short Course, and Training Seminar CatalogMarch 2018 – August 2018

Cambridge

HEALTHTECHInstitute

Cambridge

HEALTHTECHInstitute

Cambridge

HEALTHTECHInstitute

Your Life Science Netw

ork

Cam

brid

ge HEALTHTECH Institute

Your Life Science Netw

ork

Cam

brid

ge HEALTHTECH Institute

Your Life Science Network

2 | Cambridge Healthtech Institute

For over 25 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.

Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.

For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.

About Cambridge Healthtech Institute

Follow us

TABLE OF CONTENTS

CONFERENCE SERIESBiological Therapeutic Products ...................................................... 4Healthcare ....................................................................................... 4Biomarkers and Diagnostics ........................................................... 5Bioprocess and Manufacturing ....................................................... 5Clinical Trials & Translational Medicine ............................................ 6Chemistry ....................................................................................... 6BioPharmaceutical Strategy ............................................................ 7Drug Discovery & Development ..................................................... 7Detection ........................................................................................ 7Drug Targets .................................................................................... 8Genomics ........................................................................................ 8Informatics and IT ........................................................................... 8Therapeutic Indications ................................................................... 9Technology and Tools for Life Sciences ........................................... 9

CONFERENCES BY DATE WITH DETAIL ....................................11-12

SHORT COURSES AND TRAINING SEMINARS ....................... 13-14

CUSTOMER SERVICEPamela GerardiDirector of Customer ServiceE: [email protected] | T: 781-972-5409

Kris WatermanSr. Customer Service RepresentativeE: [email protected] | T: 781-972-5413

Rose LaRaiaCustomer Service RepresentativeE: [email protected] | T: 781-972-5400

MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441

Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456

SPONSOR & EXHIBIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467

Joseph Vacca, M.S.,Director, Business DevelopmentE: [email protected] | T: 781-972-5431

GROUP SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472

GRAPHICSThomas NortonDesign DirectorE: [email protected] | T: 781-972-5440

PRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423

Christina LinghamExecutive Director, Conferences and FellowE: [email protected] | T: 781-972-5464

Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497

Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139

Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709

Marina FilshtinskyExecutive Director of ConferencesE: [email protected] | T: 781-97205496

CONTACT US

@CHI_Healthtech

LinkedIn.com/company/Cambridge-Healthtech-Institute

Facebook.com/HealthtechConferences

YouTube.com/user/CambridgeHealthtechCambridge Healthtech Institute 250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288

F: (781) 972-5425

March 2018 – August 2018 | 3

2018 KEY EVENTS

Drug DiscoveryChemistry

April 2-6, 2018Hilton San Diego Bayfront

San Diego, CA

DrugDiscoveryChemistry.com

April 30 – May 4, 2018Seaport World Trade Center

Boston, MA

PEGSummit.com

May 15-17, 2018Seaport World Trade Center

Boston, MA

Bio-ITWorldExpo.com

June 11-13, 2018The Westin Boston Waterfront

Boston, MA

BiomarkerWorldCongress.com

June 18-21, 2018The Westin Copley Place

Boston, MA

WorldPreclinicalCongress.com

August 13-17, 2018Sheraton Boston

Boston, MA

BioprocessingSummit.com

ONE STOP SHOP AFFILIATED REPORTSCOLLECTION

for Over 1,000 Life Science Reports Spanning over 50 Research Areas

Insight Pharma Reports offers:

4 Market Data4 Pipeline Data4 Clinical Trial Data

4 Market Research4 Custom Reports4 Bundled Report Packages

For more information, contact Daniel Miller at: [email protected] or call (781) 972-5492

InsightPharmaReports.com

Just some of the Reports Available Include:

• Alzheimer’s Disease• Biomarkers & Diagnostics• BioPharma Strategy• Biosimilars & Generic Markets• Cancer Research and Therapeutics• Chemistry• Clinical Trials &

Translational Medicine

• Data Mining• Drug Discovery & Development• Health IT• Infectious Disease• Medical Devices• Multiple Sclerosis• Ocular• Pain Management• Pharmaceutical Marketing• Sequencing• Vaccines

...and many others

An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity. Available through Insight Pharma Reports and our Network of Affiliated Reports.

Next GenerationSUMMIT

August 20-24, 2018Grand Hyatt Washington

Washington, DCNextDenerationDx.com


Conferences by Series

Biological Therapeutic Products

Biotherapeutics Analytical SummitMar. 12-16 • Baltimore, MD

Method Development, Qualification & ValidationMar. 12-13 • Baltimore, MD

Characterizing Aggregates & ImpuritiesMar. 12-13 • Baltimore, MD

Advances in Characterization Methods & ApproachesMar. 13-14 • Baltimore, MD

Comparability & BiosimilarityMar. 15-16 • Baltimore, MD

Immuno-Oncology Summit EuropeMar. 19-23 • London, UK

Adoptive T-Cell TherapyMar. 19-20 • London, UK

Combination ImmunotherapyMar. 20-21 • London, UK

Immunomodulatory AntibodiesMar. 22-23 • London, UK

Oligonucleotide Discovery and DeliveryMar. 26-28 • Cambridge, MA

Peptide Discovery and DeliveryMar. 26-27 • Cambridge, MA

Display of AntibodiesApr. 30 - May 1• Boston, MA

Difficult to Express ProteinsApr. 30 - May 1• Boston, MA

Emerging Indications for Therapeutic AntibodiesApr. 30 - May 1• Boston, MA

Characterization of BiotherapeuticsApr. 30 - May 1 • Boston, MA

Antibodies for Cancer TherapyApr. 30 - May 1 • Boston, MA

Improving Immunotherapy Efficacy and SafetyApr. 30 - May 1 • Boston, MA

Fusion Protein TherapeuticsApr. 30 - May 1 • Boston, MA

Engineering AntibodiesMay 2-3 • Boston, MA

Biophysical Analysis of BiotherapeuticsMay 2-3 • Boston, MA

Immunogenicity Assessment and Regulatory Approval of BiologicsMay 2-3 • Boston, MA

Engineering Antibody-Drug ConjugatesMay 2-3 • Boston, MA

Advancing Bispecific Antibodies and Combination Therapy to the ClinicMay 2-3 • Boston, MA

CAR Ts, TCRs and TILsMay 2-3 • Boston, MA

CRISPR for Genome EngineeringMay 2-3 • Boston, MA

Protein Aggregation and Stability in BiopharmaceuticalsMay 3-4 • Boston, MA

Engineering Bispecific AntibodiesMay 3-4 • Boston, MA

Agonist Immunotherapy TargetsMay 3-4 • Boston, MA

Clinical Progress of Antibody-Drug ConjugatesMay 3-4 • Boston, MA

Optimizing Bioassays for BiologicsMay 3-4 • Boston, MA

Combination ImmunotherapyJun. 11-12 • Boston, MA

Intrinsic and Acquired Resistance to ImmunotherapyJun. 12-13 • Boston, MA

Preclinical Strategies, Models & Tools in OncologyJun. 19-20 • Boston, MA

Optimizing Drug Metabolism & Pharmacokinetics Jun. 19-20 • Boston, MA

Predicting Drug ToxicityJun. 20-21 • Boston, MA

Tumor Models for Cancer ImmunotherapyJun. 20-21 • Boston, MA

Translational Strategies in CNSJun. 20-21 • Boston, MA

Immuno-Oncology TargetsJun. 20-21 • Boston, MA

Extracellular VesiclesJun. 20-21 • Boston, MA

Gene Therapy BioproductionAug. 16-17 • Boston, MA

The Immuno-Oncology SummitAug. 27-31 • Boston, MA

Rational Combination Cancer ImmunotherapyAug. 27-28 • Boston, MA

Immunomodulatory Therapeutic Antibodies for CancerAug. 27-28 • Boston, MA

Oncolytic Virus ImmunotherapyAug. 27-28 • Boston, MA

Adoptive T Cell Therapy 1: DiscoveryAug. 28-29 • Boston, MA

Preclinical and Translational Immuno-OncologyAug. 28-29 • Boston, MA

Bispecific Antibodies for Cancer ImmunotherapyAug. 28-29 • Boston, MA

Emerging Immuno-Oncology TargetsAug. 30-31 • Boston, MA

Neoantigen Targeted TherapiesAug. 30-31 • Boston, MA

Adoptive T Cell Therapy 2: DevelopmentAug. 30-31 • Boston, MA

Bridge to Pop Health EastMay 14-15 • Boston, MA

Integrating Your Predictive Models into Your Clinical WorkflowMay 14-15 • Boston, MA

Innovation in Clinical Care Delivery in a Value-Based WorldMay 14-15 • Boston, MA

Data Visualization & Exploration ToolsMay 15-17 • Boston, MA

Mastering Medicinal Chemistry Part 1Jun. 19-20 • Boston, MA

Mastering Medicinal Chemistry Part 2Jun. 20-21 • Boston, MA

March 2018 – August 2018 | 5


BioinformaticsMay 15-17 • Boston, MA

BIOSENSORS: Medical Sensors for Integrated Healthcare ApplicationsMay 16-17 • Boston, MA

Molecular Diagnostics EuropeMay 22-24 • Lisbon, Portugal

Advances in Prenatal Molecular DiagnosticsMay 22-23 • Lisbon, Portugal

Clinical Application of Cell-Free DNAMay 22-23 • Lisbon, Portugal

Advanced Diagnostics for Infectious DiseaseMay 22-23 • Lisbon, Portugal

Point-of-Care DiagnosticsMay 23-24 • Lisbon, Portugal

Circulating Tumour CellsMay 23-24 • Lisbon, Portugal

Biomarkers & Immuno-Oncology World CongressJun. 11-13 • Boston, MA

Clinical and Translational BiomarkersJun. 11-12 • Boston, MA

Immuno-Oncology Biomarkers 1: Predictive Biomarkers and Companion DiagnosticsJun. 11-12 • Boston, MA

Digital Biomarkers: Biosensors, Wearables, and mHealthJun. 11-12 • Boston, MA

Immuno-Oncology Biomarkers 2: Immune Profiling and Immune MonitoringJun. 12-13 • Boston, MA

Biomarkers for Patient SelectionJun. 12-13 • Boston, MA


Extracellular VesiclesJun. 20-21 • Boston, MA

The Liquid Biopsy SummitJun. 20-22 • San Francisco, CA

Biodefense World SummitJun. 27-29 • Bethesda, MD

Biodetection Technologies: Biothreat and Pathogen DetectionJun. 26-27 • Bethesda, MD

Rapid Detection for Food SafetyJun. 27-28 • Bethesda, MD

Biosurveilance IntegrationJun. 29 • Bethesda, MD

Biodetection Technologies: Point-of-Care for BiodefenseJun. 27-28 • Bethesda, MD

Next Generation Dx SummitAug. 20-24 • Washington, DC

Enabling Point-of-Care DiagnosticsAug. 20-21 • Washington, DC

Companion Diagnostics: Strategy and PartnershipAug. 20-21 • Washington, DC

Clinical NGS AssaysAug. 20-21 • Washington, DC

Biomarkers for Cancer Immunotherapy and CombinationsAug. 20-21 • Washington, DC

Sample Prep, Assay Development and ValidationAug. 22-23 • Washington, DC

Molecular Diagnostics for Infectious DiseaseAug. 22-23 • Washington, DC

Companion and Complementary Diagnostics in Immuno-Oncology Aug. 22-23 • Washington, DCCommercializing Molecular Diagnostics in Pharma, Healthcare and the ClinicAug. 22-23 • Washington, DC

Clinical Application of Cell-Free DNAAug. 22-23 • Washington, DC

Coverage and Reimbursement for Advanced DiagnosticsAug. 23-24 • Washington, DC

Single Cell AnalysisAug. 23-24 • Washington, DC

Microfluidics and Lab-on-a-Chip Devices for POCTAug. 23-24 • Washington, DC

The Immuno-Oncology SummitAug. 27-31 • Boston, MA

Oncolytic Virus ImmunotherapyAug. 27-28 • Boston, MA

Immuno-Oncology Biomarkers 1: Quantitative Immune Profiling and Immune MonitoringAug. 27-28 • Boston, MA

Immuno-Oncology Biomarkers 2: Predictive Biomarkers and Companion DiagnosticsAug. 28-29 • Boston, MA

Immuno-Oncology Investing and Partnering ForumAug. 30 • Boston, MA

Bioprocessing Summit EuropeMar. 20-22 • Lisbon, Portugal

Optimising Cell Culture TechnologyMar. 20-21 • Lisbon, Portugal

Continuous Processing for BiopharmaceuticalsMar. 20-21 • Lisbon, Portugal

Advances in Recovery and PurificationMar. 21-22 • Lisbon, Portugal

Bioproduction: Scale, Bioreactors and DisposablesMar. 21-22 • Lisbon, Portugal

Targeting Complex Membrane ProteinsApr. 4-5 • San Diego, CA

Difficult to Express ProteinsApr. 30 - May 1 • Boston, MA

Characterization of BiotherapeuticsApr. 30 - May 1 • Boston, MA

Biophysical Analysis of BiotherapeuticsMay 2-3 • Boston, MA

Optimizing Protein ExpressionMay 2-3 • Boston, MA

Immunogenicity Assessment and Regulatory Approval of BiologicsMay 2-3 • Boston, MA

Protein Aggregation and Stability in BiopharmaceuticalsMay 3-4 • Boston, MA

Optimizing Bioassays for BiologicsMay 3-4 • Boston, MA

Protein Expression System EngineeringMay 3-4 • Boston, MA

The Bioprocessing SummitAug. 13-17 • Boston, MA

Optimizing Cell Culture TechnologyAug. 13-14 • Boston, MA

Overcoming Formulation Challenges for Biopharmaceuticals DevelopmentAug. 13-14 • Boston, MA

Rapid Methods to Assess Quality & Stability of BiologicsAug. 13-14 • Boston, MA


Conferences by SeriesContinuous Processing in Biopharm ManufacturingAug. 13-14 • Boston, MA

Cell Therapy CMC and AnalyticsAug. 13-14 • Boston, MA

Host Cell ProteinsAug. 13-14 • Boston, MA

High-Concentration Protein FormulationsAug. 15-16 • Boston, MA

Bioproduction: Scale, Bioreactors & DisposablesAug. 15-16 • Boston, MA

Accelerating Analytical DevelopmentAug. 15-16 • Boston, MA

Advances in Purification & RecoveryAug. 15-16 • Boston, MA

Cell Therapy ManufacturingAug. 15-16 • Boston, MA

Gene Therapy CMC and AnalyticsAug. 15-16 • Boston, MA

Manufacturing 4.0Aug. 15-16 • Boston, MA

Detection, Characterization and Control of Impurities in BiologicsAug. 16-17 • Boston, MA

Optimizing Cell Line DevelopmentAug. 16-17 • Boston, MA

Process Characterization and ControlAug. 16-17 • Boston, MA

Gene Therapy BioproductionAug. 16-17 • Boston, MA

Immuno-Oncology Summit EuropeMar. 19-23 • London, UK

Drug Discovery for Rare Diseases Mar. 28 • Cambridge, MA

Immunogenicity Case Studies and Clinical ManagementApr. 30 - May 1 • Boston, MA

Clinical Progress of Antibody-Drug ConjugatesMay 3-4 • Boston, MA

Clinical Trial Innovation SummitMay 7-9 • Boston, MA

Mastering Risk-Based Monitoring: Ensuring Quality in Clinical TrialsMay 7-8 • Boston, MA

Patient Recruitment & Site SelectionMay 7-8 • Boston, MA

Big Data Analytics, Machine Learning, and Artificial Intelligence for Clinical TrialsMay 7-8 • Boston, MA

Mastering Risk-Based Monitoring: Effective Monitoring & ImplementationMay 8-9 • Boston, MA

Outsourcing for Clinical TrialsMay 8-9 • Boston, MA

Data & Tech Driven Clinical TrialsMay 8-9 • Boston, MA

Clinical Research & Translational InformaticsMay 15-17 • Boston, MA

Clinical GenomicsMay 15-17 • Boston, MA

Cancer InformaticsMay 15-17 • Boston, MA


Clinical and Translational BiomarkersJun. 11-12 • Boston, MA

Digital Biomarkers: Biosensors, Wearables, and mHealthJun. 11-12 • Boston, MA

Intrinsic and Acquired Resistance to ImmunotherapyJun. 12-13 • Boston, MA

Precision MedicineAug. 23-24 • Washington, DC

Biomarkers for Patient SelectionJun. 12-13 • Boston, MA

Immuno-Oncology Biomarkers 2: Predictive Biomarkers and Companion DiagnosticsAug. 28-29 • Boston, MA

Preclinical and Translational Immuno-OncologyAug. 28-29 • Boston, MA

Personalized Cancer VaccinesAug. 30-31 • Boston, MA


Oligonucleotide and Peptide Therapeutics Boston Mar. 26-28 • Cambridge, MA

Drug Discovery ChemistryApr. 2-6 • San Diego, CA Fragment-Based Drug DiscoveryApr. 3-4 • San Diego, CA

Kinase Inhibitor ChemistryApr. 3-4 • San Diego, CA

Macrocyclics & Constrained PeptidesApr. 4-5 • San Diego, CA

Small Molecules for Cancer ImmunotherapyApr. 4-5 • San Diego, CA

PEGS: The Essential Protein Engineering Summit Apr. 30 - May 4 • Boston, MA

Phenotypic Screening and Chemical BiologyJun. 19-20 • Boston, MA

Mastering Medicinal Chemistry - Part 1Jun. 19-20 • Boston, MA

Mastering Medicinal Chemistry - Part 2Jun. 20-21 • Boston, MA

March 2018 – August 2018 | 7


Method Development, Qualification & ValidationMar. 12-13 • Baltimore, MD

Characterizing Aggregates & ImpuritiesMar. 12-13 • Baltimore, MD

Advances in Characterization Methods & ApproachesMar. 13-14 • Baltimore, MD


Peptide Discovery and Delivery Mar. 26-27 • Cambridge, MA

Immunogenicity Case Studies and Clinical ManagementApr. 30 - May 1 • Boston, MA

Strategic Alliance Management CongressMay 7-9 • Philadelphia, PA

Patient Recruitment & Site SelectionMay 7-8 • Boston, MA

Outsourcing for Clinical TrialsMay 8-9 • Boston, MA

Pharmaceutical R&D InformaticsMay 15-17 • Boston, MA

Precision MedicineAug. 23-24 • Washington, DC

Oligonucleotide and Peptide TherapeuticsMar. 26-28 • Cambridge, MA



Drug Discovery for Rare DiseasesMar. 28 • Cambridge, MA

Drug Discovery ChemistryApr. 2-6 • San Diego, CA

Small Molecules for Cancer ImmunotherapyApr. 4-5 • San Diego, CA

Lead Optimization for Drug Metabolism and SafetyApr. 6 • San Diego, CA

PEGS: The Essential Protein Engineering SummitApr. 30 - May 4 • Boston, MA

Improving Immunotherapy Efficacy and SafetyApr. 30 - May 1 • Boston, MA

Fusion Protein TherapeuticsApr. 30 - May 1 • Boston, MA

Engineering AntibodiesMay 2-3 • Boston, MA

CRISPR for Genome EngineeringMay 2-3 • Boston, MA

Nanotechnology in MedicineMay 3-4 • Boston, MA

Pharmaceutical R&D InformaticsMay 15-17 • Boston, MA

Machine LearningMay 15-17 • Boston, MA


Combination ImmunotherapyJun. 11-12 • Boston, MA

World Preclinical CongressJun. 18-21 • Boston, MA

CNS Disease ModelsJun. 19-20 • Boston, MA

Optimizing Drug Metabolism & PharmacokineticsJun. 19-20 • Boston, MA

iPS Cells for Disease Modeling and Drug DiscoveryJune 19-20 • Boston, MA

Blood-Brain BarrierJun. 19-20 • Boston, MA

NanoDrugs: Design and DeliveryJun. 19-20 • Boston, MA

Tumoroids for Oncology ResearchJun. 19-20 • Boston, MA

3D Cellular ModelsJun. 20-21 • Boston, MA

Predicting Drug ToxicityJun. 20-21 • Boston, MA

High-Content AnalysisJun. 20-21 • Boston, MA

Next-Gen Genomics: Leveraging CRISPR & Single-CellsJun. 20-21 • Boston, MA

Overcoming Formulation Challenges for Biopharmaceuticals DevelopmentAug. 13-14 • Boston, MA

Rational Combination Cancer ImmunotherapyAugust 27-28 • Boston, MA

Adoptive T Cell Therapy 1: DiscoveryAug. 28-29 • Boston, MA

Personalized Cancer VaccinesAug. 30-31 • Boston, MA


Nanotechnology in MedicineMay 3-4 • Boston, MA

Enabling Point-of-Care DiagnosticsAug. 20-21 • Washington, DC

Companion Diagnostics: Strategy and PartnershipAug. 20-21 • Washington, DC

Circulating Tumor CellsAug. 20-21 • Washington, DC


Sample Prep, Assay Development and ValidationAug. 22-23 • Washington, DC

Companion and Complementary Diagnostics in Immuno-OncologyAug. 22-23 • Washington, DC

Commercializing Molecular DiagnosticsAug. 22-23 • Washington, DC


Coverage and Reimbursement for Advanced DiagnosticsAug. 23-24 • Washington, DC

Microfluidics and Lab-on-a-Chip Devices for POCTAug. 23-24 • Washington, DC



Drug TargetsSERIES

Oligonucleotide and Peptide Therapeutics BostonMar. 26-28 • Cambridge, MA

Drug Discovery ChemistryApr. 2-6 • San Diego, CA

Kinase Inhibitor ChemistryApr. 3-4 • San Diego, CA

Protein-Protein InteractionsApr. 3-4 • San Diego, CA

GPCR-Targeted Drug DesignApr. 3-4 • San Diego, CA

PEGS: The Essential Protein Engineering SummitApr. 30 - May 4 • Boston, MA

Phenotypic Screening and Chemical BiologyJun. 19-20 • Boston, MA

NanoDrugs: Design and DeliveryJun. 19-20 • Boston, MA

Tumoroids for Oncology ResearchJun. 19-20 • Boston, MA

3D Cellular ModelsJun. 20-21 • Boston, MA

High-Content AnalysisJun. 20-21 • Boston, MA



Emerging Immuno-Oncology TargetsAug. 30-31 • Boston, MA

Next-Gen Sequencing InformaticsMay 15-17 • Lisbon, Portugal

Clinical Application of Cell-Free DNAMay 22-23 • Lisbon, Portugal


Immuno-Oncology Biomarkers 2: Immune Profiling and Immune MonitoringJun. 12-13 • Boston, MA

Next-Gen Genomics: Leveraging CRISPR & Single-CellsJun. 20-21 • Boston, MA


Clinical NGS Assays: Interpretation and Clinical UtilityAug. 20-21 • Washington, DC

Commercializing Molecular Diagnostics in Pharma, Healthcare and the ClinicAug. 22-23 • Washington, DC

Single Cell AnalysisAug. 23-24 • Washington, DC


Immuno-Oncology Biomarkers 1: Quantitative Immune Profiling and Immune MonitoringAug. 27-28 • Boston, MA

Neoantigen Targeted TherapiesAug. 30-31 • Boston, MA

Clinical Trial Innovation SummitMay 7-9 • Boston, MA

Big Data Analytics, Machine Learning, and Artificial Intelligence for Clinical TrialsMay 7-8 • Boston, MA

Mastering Risk-Based Monitoring: Effective Monitoring & ImplementationMay 8-9 • Boston, MA

Data & Tech Driven Clinical TrialsMay 8-9 • Boston, MA

Bridge to Pop Health EastMay 14-15 • Boston, MA

Integrating Your Predictive Models into Your Clinical WorkflowMay 14-15 • Boston, MA

Innovation in Clinical Care Delivery in a Value-Based WorldMay 14-15 • Boston, MA

Bio-IT WorldMay 15-17 • Boston, MA

Data & Storage ManagementMay 15-17 • Boston, MA

Software Applications & ServicesMay 15-17 • Boston, MA

Data ComputingMay 15-17 • Boston, MA

Cloud ComputingMay 15-17 • Boston, MA

BioinformaticsMay 15-17 • Boston, MA

Next-Gen Sequencing InformaticsMay 15-17 • Boston, MA

Clinical GenomicsMay 15-17 • Boston, MA

FAIR Data for Genomic ApplicationsMay 15-17 • Boston, MA


Data SecurityMay 15-17 • Boston, MA

Machine LearningMay 15-17 • Boston, MA

Data TransferMay 15-17 • Boston, MA

Disease Surveillance & ModelingMay 15-17 • Boston, MA

Manufacturing 4.0Aug. 15-16 • San Francisco, CA

March 2018 – August 2018 | 9

SERIESAdoptive T-Cell TherapyMar. 19-20 • London, United Kingdom

Combination ImmunotherapyMar. 20-21 • London, United Kingdom

Immunomodulatory AntibodiesMar. 22-23 • London, United Kingdom

Inflammation and Autoimmune InhibitorsApr. 3-4 • San Diego, CA

Blood-Brain Penetrant InhibitorsApr. 6 • San Diego, CA

Emerging Indications for Therapeutic AntibodiesApr. 30 - May 1 • Boston, MA

Antibodies for Cancer TherapyApr. 30 - May 1 • Boston, MA

Engineering Antibody-Drug ConjugatesMay 2-3 • Boston, MA

Advancing Bispecific Antibodies and Combination Therapy to the ClinicMay 2-3 • Boston, MA

CAR Ts, TCRs and TILsMay 2-3 • Boston, MA

Agonist Immunotherapy TargetsMay 3-4 • Boston, MA

Immuno-Oncology Biomarkers 1: Predictive Biomarkers and Companion DiagnosticsJun. 11-12 • Boston, MA

Preclinical Strategies, Models & Tools in OncologyJun. 19-20 • Boston, MA

CNS Disease ModelsJun. 19-20 • Boston, MA

iPS Cells for Disease Modeling and Drug DiscoveryJun. 19-20 • Boston, MA

Blood-Brain BarrierJun. 19-20 • Boston, MA

Tumor Models for Cancer ImmunotherapyJun. 20-21 • Boston, MA

Immuno-Oncology TargetsJun. 20-21 • Boston, MA

The Liquid Biopsy SummitJun. 20-22 • San Francisco, CA

Rapid Methods to Assess Quality & Stability of BiologicsAug. 13-14 • Boston, MA

Cell Therapy CMC and AnalyticsAug. 13-14 • Boston, MA

The Bioprocessing SummitAug. 13-17 • Boston, MA

Cell Therapy ManufacturingAug. 15-16 • Boston, MA

Detection, Characterization and Control of Impurities in BiologicsAug. 16-17 • Boston, MA

Process Characterization and ControlAug. 16-17 • Boston, MA



Immunomodulatory Therapeutic Antibodies for CancerAug. 27-28 • Boston, MA


Adoptive T Cell Therapy 2: DevelopmentAug. 30-31 • Boston, MA

Biotherapeutics Analytical SummitMar. 12-16 • Baltimore, MD




Targeting Complex Membrane ProteinsApr. 4-5 • San Diego, CA

Ubiquitin Proteasome System InhibitorsApr. 4-5 • San Diego, CA

Biophysical Approaches for Drug DiscoveryApr. 6 • San Diego, CA

Display of AntibodiesApr. 30 - May 1 • Boston, MA

Optimizing Protein ExpressionMay 2-3 • Boston, MA

Protein Expression System EngineeringMay 3-4 • Boston, MA

Bio-IT WorldMay 15-17 • Boston, MA

Data & Storage ManagementMay 15-17 • Boston, MA

Software Applications & ServicesMay 15-17 • Boston, MA

Data ComputingMay 15-17 • Boston, MA

Cloud ComputingMay 15-17 • Boston, MA

Clinical Research & Translational InformaticsMay 15-17 • Boston, MA

Data Visualization & Exploration ToolsMay 15-17 • Boston, MA

FAIR Data for Genomic ApplicationsMay 15-17 • Boston, MA


Data SecurityMay 15-17 • Boston, MA

Data TransferMay 15-17 • Boston, MA

Disease Surveillance & ModelingMay 15-17 • Boston, MA

Clinical Application of Circulating Cell-Free DNAMay 22-23 • Lisbon, Portugal

Circulating Tumour CellsMay 23-24 • Lisbon, Portugal

Enabling Technologies for Cell-Free DNAMay 23-24 • Lisbon, Portugal

World Preclinical CongressJun. 18-21 • Boston, MA

Extracellular VesiclesJune 20-21 • Boston, MA

Biodefense World SummitJun. 27-29 • Bethesda, MD

Continuous Processing in Biopharm ManufacturingAug. 13-14, 2018 • Boston, MA

Advances in Purification & RecoveryAug. 15-16 • Boston, MA



Conferences by Date with Detail

Biotherapeutics Analytical SummitMarch 12-16, 2018 • Baltimore, MDThe Biotherapeutics Analytical Summit, with its hallmark brand of topics on Method Development, Qualification & Validation, Advances in Characterization Methods & Approaches and Comparability & Biosimilarity, and its signature mix of regulators, industry and academia speakers, has come to be known as THE Analytical Summit where attendees can hear and learn about real-life case studies, innovative concepts and practical approaches that can help scientists advance their molecules from discovery to development and commercialization. New this year is a dedicated conference on “Characterizing Aggregates & Impurities.” Previously a part of the Advances in Characterization Methods conference, we are responding to your request to dedicate more time and focus on this challenging and dynamic topic.

BiotherapeuticsAnalyticalSummit.com

Immuno-Oncology Summit EuropeMarch 19-23, 2018 • London, United KingdomCambridge Healthtech Institute’s Third Annual Immuno-Oncology Summit Europe returns to the heart of London’s Canary Wharf for a full week of cutting-edge science and discussion. Through three back-to-back conference tracks, delegates will hear from the research teams at the forefront of the rapidly developing field of cancer biotherapeutics. Cambridge Healthtech Institute brings you the highest standard of scientific content and collaboration with more than 130 conferences across the globe, including the industry leading PepTalk, PEGS Protein & Antibody Engineering Summits and Immuno-Oncology Summits held each year in North America, Europe and Asia. We look forward to seeing you at what promises to be another successful knowledge-sharing event.

Immuno-OncologyEurope.com

Bioprocessing Summit EuropeMarch 20-22, 2018 • Lisbon, PortugalBioprocessing Summit Europe brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for today’s bioprocessing needs. Created by the producers of PEGS, PepTalk and The Bioprocessing Summit Boston, this four-conference, scientifically driven event presents detailed case studies, technology updates, and best practice in cell culture, scale-up, recovery, purification, continuous manufacturing, process intensification, and bioproduction. Along with the impressive array of conferences, the Summit also features Short Courses, interactive Breakout Sessions and a lively Exhibit Hall to provide in-depth coverage of critical bioprocess topics.

BioprocessingEurope.com

Oligonucleotide and Peptide TherapeuticsMarch 26-28, 2018 • Cambridge, MAIt has been estimated that only a fraction of known disease targets have been successfully met with therapeutic options. As our understanding of disease biology continues to outpace our ability to develop therapeutic agents, there is an urgent need to find new ways to unlock a greater portion of this “undruggable” target space. Oligonucleotide and peptide therapeutics have emerged as critical development platforms to meet this challenge, poised to produce highly specific, diverse and safe therapies while addressing a much wider range of targets than traditional small molecules or biologics. CHI’s Third Annual Oligonucleotide & Peptide Therapeutics (OPT) Boston will once again convene leading developers and technology providers to discuss advances in next-generation oligonucleotide and peptide therapies. This three-day event includes two main conferences covering topics within discovery, delivery, and early clinical studies, as well as a symposium focused on utilizing oligonucleotides and peptides to address rare diseases.

OPTCongress.com

Drug Discovery ChemistryApril 2-6, 2018 • San Diego, CACambridge Healthtech Institute’s 13th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one’s personal interests by going back and forth among concurrent meeting tracks. New for 2018 is expanded coverage of Small Molecules for Cancer Immunotherapy, plus new coverage of Ubiquitin Proteasome System Inhibitors, Targeting Complex Membrane Proteins, as well as Lead Optimization for Drug Safety.

DrugDiscoveryChemistry.com

PEGS: The Essential Protein & Antibody Engineering SummitApril 30, 2018 - May 4, 2018 • Boston, MAPEGS: The Essential Protein Engineering Summit is one of the industry’s most preeminent events that inspires accelerated biotherapeutic protein drug development. This weeklong event attracts over 2,300 international participants, and features nearly 400 presentations by world renowned leaders from pharma, academia, and government showcasing case studies, cutting edge data, insight and perspective. Conference programs include a broad spectrum of topics including protein and antibody engineering, cancer immunotherapy, oncology, and emerging therapeutics.

PEGSummit.com

March 2018 – August 2018 | 11


Neurotech Investing & Partnering ConferenceMay 1-2, 2018 • Boston, MANow in its 13th year, the Neurotech Investing & Partnering Conference is the premier business and investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients. The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry. This market-defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.

NeurotechPartnering.com

Strategic Alliance Management CongressMay 7-9, 2018 • Boston, MAThe approval of new therapies increasingly relies on an ecosystem of strategic partnerships during various stages of the development pipeline. Successfully managing these partnerships has become a critical component to the underlying success of each partner and the biopharma industry. As the quantity and complexity of deals increase, alliance teams have rapidly evolved, developing innovative strategies, systematic approaches and best practices to maximize value, and to leverage strategic partnerships above and beyond the deal. Cambridge Healthtech Institute’s 15th Annual Strategic Alliance Management Congress, May 7-9, brings together senior alliance management, business development, technology transfer and licensing professionals, to network, share experiences, discuss case studies, and to share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of alliance management.

Healthtech.com/AMS

Clinical Trial Innovation SummitMay 7-9, 2018 • Boston, MACambridge Healthtech Institute’s Clinical Trial Innovation Summit brings together 250 leaders from across pharma, biotech and academia for the perfect blend of high quality presentations and intimate networking. Through case studies, interactive discussions and an active exhibit hall, the summit delivers the real-world experiences and best practices needed to optimize clinical trial oversight. Presentations span across the most complex areas of trial management, including patient recruitment, site selection, data integration, existing data sources, mobile technologies, project management, outsourcing, vendor management, budgeting and contracting, quality (QbD) in trial conduct and risk-based monitoring.

ClinicalTrialSummit.com

Bridge to Pop Health EastMay 14-15, 2018 • Boston, MAFormerly known as Medical Informatics World, Cambridge Healthtech Institute’s Sixth Annual Bridge to Pop Health Conference in Boston brings together thought leaders from the provider, payer, healthcare finance, analyst and technology communities for insightful discussions on maximizing clinical quality. The two-day executive conference will cover operational performance in risk-based contracts, integrating your predictive models into your clinical workflow, innovation in clinical care delivery in a value-based world, and implementing a population health management strategy in the transitional space between fee-for-service and value-based care. We look forward to seeing you at what promises to be a productive step forward for our industry.

BridgeToPopHealth.com/East

Bio-IT WorldMay 15-17, 2018 • Boston, MAThere’s been dramatic progress in life science technologies over the years, yet the fundamental goal of the Bio-IT community remains the same — to make the most of data and computing to advance medicine. Since 2002, Bio-IT World has played an integral role in this, bringing together clever, innovative people from all areas of life sciences for expert commentary and industry insight. Our 2017 event brought together more than 3,400 attendees from 35 countries to make connections and forge collaborations across the life sciences. Next year promises to be even better. With 16 tracks, 14 pre-conference workshops, and three industry awards, the 2018 Bio-IT World Conference & Expo will offer more opportunities to build the relationships that drive the Bio-IT industry forward.

Bio-ITWorldExpo.com

BiosensorsMay 16-17, 2018 • Boston, MAEmerging technological innovations enabled by next-generation sensors will define the landscape for the future commercialization of life changing medical devices. The exponential growth of the global sensors market and the demand for next-generation integrated systems is expected to reach $18 billion by 2018. Low cost materials and advances in nano and micro fabrication techniques within the manufacturing process have led to significant increases in the commercialization of sensors for healthcare applications. Cambridge Healthtech Institute’s Biosensors conference, which will take place at the Aloft Boston Seaport Hotel, will examine the latest advancements in research and integration and will provide attendees with state-of-the-art sensors development for medical applications.

MedicalBiosensors.com

Molecular Diagnostics EuropeMay 22-24, 2018 • Lisbon, PortugalCambridge Healthtech Institute’s Sixth International Molecular Diagnostics Europe event will return to Lisbon on 22-24 May 2018. This meeting provides a nexus for diagnostic developers in academia and industry as well as end-users in the pharmaceutical and healthcare sector to gain a comprehensive picture of molecular diagnostics in prenatal, oncology, infectious disease, point-of-care, liquid biopsy, and immunotherapy. This exciting area has attracted attendance of over 400 delegates to learn what novel technologies, platforms and applications are emerging that will impact future healthcare delivery and pharmaceutical research. Join us next spring at this expanding event at the epicenter of diagnostics.

MolecularDxEurope.com



Biomarkers & Immuno-Oncology World CongressJune 11-13, 2018 • Boston, MACambridge Healthtech Institute’s Fourteenth Annual Biomarkers and Immuno-Oncology World Congress, now in Boston, is our longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. With the promising developments in immuno-oncology over the past years, much of the biomarker R&D has shifted to discovery and development of predictive biomarkers for immunotherapy patient stratification, using biomarkers to choose rational combination immunotherapy, and applying immune profiling to predict and monitor response to immunotherapy. The Immuno-Oncology Biomarkers stream will address predictive biomarkers and companion diagnostics, as well as immune profiling and immune monitoring. The Immunotherapy stream will address the two biggest challenges in pharmaceutical IO programs: designing rational combination immunotherapies and strategies to address intrinsic and acquired resistance. Finally, a new track on Digital Biomarkers will cover the clinical utility of biosensors, wearables and mobile health, and their emerging applications in drug development.

BiomarkerWorldCongress.com

World Preclinical CongressJune 18 - 21 • Boston, MAThe 17th Annual World Preclinical Congress focuses on the latest trends and technologies impacting drug discovery and translational research. The Congress offers a unique opportunity for chemists, biologists, pharmacologists, cancer researchers, neuroscience scientists, toxicologists, bioengineers, screening experts and translational scientists in industry and academia as well as technology providers to come together and exchange expertise and opinions. World Preclinical Congress is a key networking event yielding new partnerships that accelerate preclinical research and translation across all therapeutic areas.

WorldPreclinicalCongress.com

The Liquid Biopsy SummitJune 20-22, 2018 • San Francisco, CAParticipants from around the world convene at The Liquid Biopsy Summit to share case studies, breakthroughs and solutions that support and enhance their research, and discuss process and technology refinements that are impacting the future of precision medicine.

LiquidBiopsySummit.com

Biodefense World SummitJune 26-29, 2018 • Bethesda, MDCambridge Healthtech Institute’s Fourth Annual Biodefense World Summit brings together leaders from government, academia, and industry for compelling discussions and comprehensive coverage on pathogen detection, point-of-care, biosurveillance, sample prep technologies, and bio recovery. Across three days of programming, attendees can expect exceptional networking opportunities in the exhibit hall, engaging panel discussions, and shared case studies with members of the biodefense community from technology providers to policy makers. The 2017 summit saw more than 250 participants with 35% of attendees titled as scientist/technologist, 30% as executive/director, and 11% as professor.

BiodefenseWorldSummit.com

The Bioprocessing SummitAugust 13-17, 2018 • Boston, MAThe Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical solutions for today’s bioprocess challenges. The event has grown to include 17 distinct conferences with weeklong programming on upstream and downstream processing, analytical development and quality, formulation and stability, cell and gene therapy production, and manufacturing. Along with the impressive array of conferences, the Summit also includes short courses and training seminars that provide in-depth coverage of critical bioprocess topics.

BioprocessingSummit.com

Next Generation Dx SummitAugust 20-24, 2018 • Washington, DCSince 2009, the diagnostics community has united at Next Generation Dx Summit to discuss trend-setting developments, milestones, challenges and opportunities in the industry. A decade later, the diagnostics industry has paved the path to the precision medicine era with tremendous advancement in rapid and non-invasive testing, cancer detection and monitoring, and expanding applications of clinical sequencing. As the market demands faster and more precise diagnostics, and regulatory and reimbursement conditions continue to evolve, diagnostic professionals need a comprehensive event that can help them build partnerships, gain industry knowledge, and network with and learn from their peers. Next Generation Dx Summit provides a venue to advance the science of diagnostics and improve the practice of medicine.

NextGenerationDx.com

The Immuno-Oncology SummitAugust 27-31, 2018 • Boston, MAJoin over 600 thought leaders at industry’s leading Immuno-Oncology event and learn about the latest research in a comprehensive 12-track program, network and build lasting collaborations with an international mix of delegates from industry and academia, and gain actionable solutions to drive your organization’s next-generation immunotherapy programs. Over the past 6 years, CHI’s Immuno-Oncology Summit became the leading annual meeting focusing on the latest applied research. The comprehensive 5-day, 12-track program covers immunomodulatory antibody engineering and emerging immuno-oncology targets, combination immunotherapy, preclinical and translational IO, predictive biomarkers and companion diagnostics, adoptive T cell therapy, oncolytic viruses and personalized cancer vaccines. The Immuno-Oncology Summit brings together a unique and international mix of large and medium pharmaceutical and biotech companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Summit a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its 6th year, the IO Summit consistently delivers a cutting-edge agenda, 600+ senior delegates, and a sold-out exhibit hall.

Immuno-OncologySummit.com

March 2018 – August 2018 | 13

Short Course & Training Seminar Schedule

SC = Short Course | TS = Training Seminar

Biotherapeutics Analytical SummitMarch 12-16, 2018 • Baltimore, MD

SC1: Particles in Biotherapeutics: Characterization & ImpactSC2: The Multi-Attribute Method (MAM) for Improving Product and Process

DevelopmentSC3: Critical Quality Attributes and Testing Strategy for Biotherapeutics

DevelopmentSC4: New Analytical Approaches & Strategies for BiosimilarityTS1: Core Principles and Best Practices for Biotech Analytical Test Methods

across the Product LifecycleTS2: Regulatory Requirements across the Product Development Lifecycle

BioProcessing Summit EuropeMarch 20-22, 2018 • Lisbon, Portugal

SC1: Optimizing Media for Culturing CellsSC2: Continuous Processing MasterclassSC3: At the Heart of PAT Lies the QbD ApproachSC4: The Challenge of Protein Aggregation and Sub Visible Particles in

Biopharmaceuticals

Immuno-Oncology Summit EuropeMarch 19-23, 2018 • London, United Kingdom

SC1: T-Cell Therapies: Current Field, Challenges and Future DirectionsSC2: T-Cell Immunotherapy Manufacturing Development Challenges: Key Factors

Shaping the FieldSC3: Preclinical Models for Cancer ImmunotherapySC4: The Tumour Microenvironment and Response to Cancer Immunotherapy

Oligonucleotide and Peptide TherapeuticsMarch 26-28, 2018 • Cambridge, MA

SC1: Oligonucleotide Therapeutics: From Discovery to ManufacturingSC2: Overcoming Challenges with Peptide DeliverySC3: CRISPR-Based Gene Editing for Targeted Therapies

Drug Discovery Chemistry April 2-6, 2018 • San Diego, CASC1: Ligand-Receptor Molecular Interactions and Drug DesignSC2: Advancing Tools and Technology for Fragment-Based DesignSC3: Drug Metabolism and Its Impact on Decisions in Lead DiscoverySC4: Diversity-Oriented Platforms for Ligand DiscoverySC5: Immunology Basics for ChemistsSC6: Introduction to Allosteric Modulators and Biased Ligands of GPCRsSC7: Introduction to Targeted Covalent InhibitorsSC8: Introduction to the Ubiquitin Proteosome SystemSC9: Impact of Convergence of Immunology and Epigenetics in Drug DiscoverySC10: Enabling Macrocyclic Compounds for Drug Discovery: Opportunities,

Challenges and StrategiesSC11: Trends in Physical Properties of DrugsSC12: Covalent Fragments: Applications in Target-Based and Phenotypic Screens

PEGS: The Essential Protein & Antibody Engineering SummitApril 30 - May 4, 2018 • Boston, MA

SC1: Preclinical and Clinical Assessment of Immunogenicity: Multidomain Therapeutics and New Modalities, Including Gene Therapy and CAR T

SC2: Translational Considerations for Development of Monoclonal Antibodies and Emerging Constructs: Part I: Focus on Construct Design

SC3: The Life Science Executive’s Fundraising ManifestoSC4: Selection, Screening and Engineering for Affinity Reagents SC5: In Silico Immunogenicity Predictions (Hands-on) WorkshopSC6: Practical Considerations for Biomarker BioanalysisSC7: Translational Considerations for Development of Monoclonal Antibodies

and Emerging Constructs: Part 2: Focus on Preclinical DevelopmentSC8: Introduction to Biophysical Analysis for Biotherapeutics: Discovery &

Development ApplicationsSC9: CAR T Cell Therapy for Solid TumorsSC10: Critical Considerations for the Design and Development of Antibody-Drug

ConjugatesSC11: Strategic/Modular Bioassay Design and AnalysisSC12: Transient Protein Production in Mammalian CellsSC13: Sub-Visible Protein Particles in Immunogenicity: Measurement,

Characterization and ImpactTS9A: Introduction to Protein EngineeringTS10A: Introduction to Structure-Based Drug Design and DevelopmentTS11A: Introduction to BioprocessingTS12A: Introduction Design of Experiments for Bioassay DevelopmentTS9B: Next-Generation Sequencing for Antibody Discovery and EngineeringTS10B: Immunology for Drug Discovery ScientistsTS8C: Introduction to Immunogenicity

Strategic Alliance Management CongressMay 7-9, 2018 • Philadelphia, PA

SC1: The Key Skills of the Alliance Manager: Models, Tools and Frameworks for Maximum Impact

Clinical Trial Innovation Summit May 7-9, 2018 • Boston, MA

SC1: Needles in a Haystack: Proven Digital Media Campaigns for Clinical Trials in Rare Diseases & Oncology

SC2: Implementing RBM and a Clinical QMS with Limited Resources

Bio-IT WorldMay 15-17, 2018 • Boston, MA

SC1: Data Management for Biologics: Registration and BeyondSC2: Common Statistical Mistakes to Avoid for Data ScientistsSC3: D2K, Transforming Data to Knowledge with Cloud, IoT & Machine Learning

(AI) – Part ISC4: Introduction to Scalable and Reproducible RNA-Seq Data Processing,

Analysis, and Result Reporting Using AWS, R, knitr, and LaTexSC5: Data Visualization to Accelerate Biological DiscoverySC6: An Intro to Blockchain in Life SciencesSC7: Containerizing Applications and Workflows for Large-Scale Reproducible

Science


Short Course & Training Seminar Schedule

HOLD A COURSE AT YOUR FACILITY.For more information, please contact Edel O’Regan at 781-972-5423 or email: [email protected]

SC8: Automating Data Analysis with ExcelSC9: D2K, Transforming Data to Knowledge with Cloud, IoT & Machine Learning

(AI) – Part IISC10: Digital Biomarkers in Pharma R&D: Technical Challenges and Strategies

for Advancing Personalized MedicineSC11: Data Science Driving Better Informed DecisionsSC12: Bio-IT IOT WorkshopSC13: Leveraging Cloud Technologies to Enable Large-Scale Integration of

Human Genome and Clinical Outcomes DataSC14: Bootstrapping Your Life Science Startup - The Good, the Bad and the Ugly

Molecular Diagnostics EuropeMay 22-24, 2018 • Lisbon, Portugal

SC1: Technologies, Applications and Commercialization of Point-of-Care Diagnostics

SC2: Preimplantation Genetic Diagnostics and ScreeningSC3: Liquid Biopsy for P4 Medicine: Predictive, Preventive, Personalized and

Paticipatory

World Preclinical CongressJune 18 - 21, 2018 • Boston, MA

SC1: Introduction to GPCR-Based Drug DiscoverySC2: Enabling Macrocyclic Compounds for Drug DiscoverySC3: Drug Metabolism and Its Impact on Decisions in Lead Discovery and Drug

DevelopmentSC4: Practical Phenotypic ScreeningSC5: Impact of Convergence of Immunotherapy and Epigenetics in OncologySC6: Collecting, Storing, and Utilizing Precious Patient-Derived Tumors for Drug

Discovery and DevelopmentSC7: How to Best Utilize 3D Cells, Spheroids, PDX Models in OncologySC8: Applications of Artificial Intelligence & Machine Learning in Drug Discovery

& DevelopmentSC9: Understanding and Dealing with Drug Disposition in CNSSC10: Humanized Mouse Models for Preclinical Assessment of Cancer

ImmunotherapySC11: DNA-Encoded Library TechnologiesSC12: Advanced Bioprinting Strategies for Generation of 3D Tissue ModelsSC13: Evaluating and Characterizing in vitro Models of Drug ToxicityTS1: Introductory Immunology for Autoimmune and Cancer Drug DiscoveryTS2: Applying Pharmacology to New Drug DiscoveryTS3: Genome Editing with Targeted NucleasesTS4: Introduction to Small Molecule Drug Discovery and DevelopmentTS5: Practical Introduction to PKPD Modeling in Drug Discovery and

DevelopmentTS6: Patient-Derived ASC-Organoids for Drug Development and Screening,

Patient Stratification and Regenerative Medicine

The Liquid Biopsy SummitJune 20-22, 2018 • San Diego, CA

SC1: Innovative Technologies for Imaging CTC Phenotype, Drug Response and Metastasis

The Bioprocessing SummitAugust 13-17, 2018 • Boston, MA

SC1: Optimizing Media-Achieving Super SoupSC2: QbD Strategies for Formulation Development of Protein TherapeuticsSC3: Operational Excellence in Bioprocessing: PAT, QbD, DoE and Continuous

ImprovementSC4: ADC “Developability”: Critical Quality Attributes Inform FormulationSC5: Extractables & LeachablesSC6: Accelerated Stability Testing of BiologicsSC7: Analytical Strategies for Comparability in Bioprocess DevelopmentSC8: Biophysical Characterization in Developing BiopharmaceuticalsSC9: ABC: Anything But Chromatography - Precipitation, Crystallization and

FlocculationSC10: Bioprocess DevelopmentTS1: Introduction to BioprocessingTS2: Current & Emerging Global Regulatory Expectations for Analytical ElementsTS3: Pharmaceutical OutsourcingTS4: Introduction to Cell CultureTS5: Introduction to Biologics Formulation and Delivery

Next Generation Dx SummitAugust 20-24, 2018 • Washington, DC

SC1: Micro- and Nanofluidics in Diagnostics and Life SciencesSC2: Boosting Your Omics and Biomarker Projects through an Efficient and

Rigorous Study DesignSC3: Latest Advances in Molecular Pathology, Part ISC4: Applications of Detection Theory in DiagnosticsSC5: Automation Solutions for Molecular DiagnosticsSC6: Business Strategies for Companion DiagnosticsSC7: Latest Advances in Molecular Pathology, Part IISC8: The Future of Point-of-Care DiagnosticsSC9: Mass Spec Methods for the Clinical LabSC10: TBASC11: TBASC12: TBA

The Immuno-Oncology SummitAugust 27-31, 2018 • Boston, MA

SC1: TBASC2: TBATS1: TBA

LEAD GENERATION

LIFE SCIENCE

PROGRAMS

Healthtech.com/Lead-Gen

WebinarsWhitepapersMarket ResearcheBooksPodcasts

Cambridge Healthtech Institute’s

Content marketing designed to fill your pipeline with targeted leads!

Increase your Sales Revenue with

Some of our database segments include:

Antibody Engineering: 30,000

Bioinformatics: 40,000

Bioprocessing: 40,000

Biomarkers: 20,000

Cancer: 30,000

Chemistry: 40,000

Clinical Trials: 50,000

Diagnostics: 60,000

Drug Discovery & Development: 35,000

Genomics: 55,000

Preclinical: 35,000

Proteomics: 38,000

Mine our database of 800,000 professionals

CHI is a division of Cambridge Innovation Institute

CHI

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-CON, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target.

About Cambridge Healthtech InstituteYour Life Science Network

healthtech.com250 First Avenue, Suite 300

Needham, Massachusetts 02494

USA Phone: 781.972.5400

Additional divisions of CHI include

healthtechpublishing.com

insightpharmareports.com

barnettinternational.com

Your Life Science Network Cambridge HEALTHTECH...Gene Therapy Bioproduction Aug. 16-17 • Boston,...

Documents

Transcript of Your Life Science Network Cambridge HEALTHTECH...Gene Therapy Bioproduction Aug. 16-17 • Boston,...